MetLife Investment Management’s Innophos Holdings, Inc. IPHS Stock Holding History

MetLife Investment Management’s Portfolio IPHS Stock Details IPHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-9,207	Closed	-$294K	–	2355
2019 Q4	$294K	Hold	9,207	–	–	﹤0.01%	1761
2019 Q3	$299K	Hold	9,207	–	–	﹤0.01%	1710
2019 Q2	$268K	Hold	9,207	–	–	﹤0.01%	1862
2019 Q1	$277K	Hold	9,207	–	–	﹤0.01%	1802
2018 Q4	$226K	Hold	9,207	–	–	﹤0.01%	1838
2018 Q3	$409K	Hold	9,207	–	–	﹤0.01%	1654
2018 Q2	$438K	Hold	9,207	–	–	0.01%	1483
2018 Q1	$370K	Hold	9,207	–	–	﹤0.01%	1558
2017 Q4	$430K	Buy	+9,207	New	+$430K	﹤0.01%	1486

Other funds holding IPHS

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

MetLife Investment Management's IPHS Position: Q1 2020 in Review

MetLife Investment Management sold out of Innophos Holdings, Inc. (IPHS) in Q1 2020, closing a stake of 9,207 shares — an estimated $294K sold.

MetLife Investment Management first reported a position in IPHS in Q4 2017 and held it in 9 quarters. The position peaked at $438K in Q2 2018. 2 funds tracked by Wall St. Rank hold IPHS as of Q1 2020.

MetLife Investment Management reported no remaining Innophos Holdings, Inc. position as of Q1 2020 after selling out during the quarter.
MetLife Investment Management sold 9,207 Innophos Holdings, Inc. shares in Q1 2020, an estimated $294K.
MetLife Investment Management first reported a position in Innophos Holdings, Inc. in Q4 2017 and held it in 9 quarters.
MetLife Investment Management's Innophos Holdings, Inc. position peaked at $438K in Q2 2018.
2 funds tracked by Wall St. Rank held Innophos Holdings, Inc. as of Q1 2020.

Based on MetLife Investment Management's 13F filing for Q1 2020, filed 15 May 2020.